These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8959987)

  • 1. Is levodopa toxic?
    Fahn S
    Neurology; 1996 Dec; 47(6 Suppl 3):S184-95. PubMed ID: 8959987
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute renal failure after massive voluntary intoxication with levodopa (MODOPAR)].
    Barcat D; Constans J; Delpeu K; Banwarth B; Conri C
    Therapie; 1998; 53(6):598-600. PubMed ID: 10070242
    [No Abstract]   [Full Text] [Related]  

  • 3. Levodopa--toxic or neuroprotective?
    Weiner WJ
    Nat Clin Pract Neurol; 2006 Oct; 2(10):518-9. PubMed ID: 16990820
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa toxicity in Parkinson disease.
    Lessell S
    Arch Neurol; 2000 Sep; 57(9):1382. PubMed ID: 10987914
    [No Abstract]   [Full Text] [Related]  

  • 5. Agonist or levodopa for Parkinson disease?: ultimately, it doesn't matter; neither is good enough.
    Weiner WJ; Reich SG
    Neurology; 2008 Aug; 71(7):470-1. PubMed ID: 18695156
    [No Abstract]   [Full Text] [Related]  

  • 6. Levodopa: 50 years of a revolutionary drug for Parkinson disease.
    Fahn S; Poewe W
    Mov Disord; 2015 Jan; 30(1):1-3. PubMed ID: 25488146
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease.
    Schapira AH
    Mov Disord; 2008; 23 Suppl 3():S515-20. PubMed ID: 18781678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 50 years of levodopa.
    Hornykiewicz O
    Mov Disord; 2015 Jun; 30(7):1008. PubMed ID: 25999218
    [No Abstract]   [Full Text] [Related]  

  • 9. [L-dopa and antiparkinson agents].
    Delwaide PJ
    Rev Med Liege; 1996 Jan; 51(1):61-4. PubMed ID: 8701139
    [No Abstract]   [Full Text] [Related]  

  • 10. Circadian rhythmicity in levodopa pharmacokinetics in patients with Parkinson disease.
    Nyholm D; Lennernäs H; Johansson A; Estrada M; Aquilonius SM
    Clin Neuropharmacol; 2010 Jul; 33(4):181-5. PubMed ID: 20661024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa for Parkinson's disease.
    Devos D; Moreau C; Destée A
    N Engl J Med; 2009 Feb; 360(9):935-6; author reply 936. PubMed ID: 19246370
    [No Abstract]   [Full Text] [Related]  

  • 12. Levodopa: back to the future.
    Zappia M; Colosimo C; Poewe W
    J Neurol; 2010 Nov; 257(Suppl 2):S247-8. PubMed ID: 21080184
    [No Abstract]   [Full Text] [Related]  

  • 13. Levodopa: the story so far.
    Abbott A
    Nature; 2010 Aug; 466(7310):S6-7. PubMed ID: 20739934
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa for Parkinson's disease.
    Gérard JM; Elosegi JA
    N Engl J Med; 2009 Feb; 360(9):936; author reply 936. PubMed ID: 19256032
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute overdose with controlled-release levodopa-carbidopa.
    Delmas G; Rothmann C; Flesch F
    Clin Toxicol (Phila); 2008 Mar; 46(3):274-7. PubMed ID: 18344112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Welcome news about levodopa, but uncertainty remains.
    Fahn S
    Ann Neurol; 1998 May; 43(5):551-4. PubMed ID: 9585348
    [No Abstract]   [Full Text] [Related]  

  • 17. What would Dr. James Parkinson think today? parcelling out the circuitry of levodopa-induced dyskinesias.
    Kordower JH
    Mov Disord; 2017 Apr; 32(4):483-484. PubMed ID: 28425143
    [No Abstract]   [Full Text] [Related]  

  • 18. [Levodopa+selegiline combination and increase of risk of mortality in the treatment of Parkinson disease].
    Dubois B; Montastruc JL
    Rev Neurol (Paris); 1996 Feb; 152(2):103-5. PubMed ID: 8761616
    [No Abstract]   [Full Text] [Related]  

  • 19. Mydriasis in a Parkinson disease patient on low-dose carbidopa/levodopa.
    Burdick DJ; Griffith A; Agarwal P
    Mov Disord; 2013 Mar; 28(3):295. PubMed ID: 23526432
    [No Abstract]   [Full Text] [Related]  

  • 20. [Epidemiological assessment of levodopa consumption].
    de Pedro-Cuesta J; Cuadrado JI
    Rev Neurol; 2000 Dec 1-15; 31(11):1028-30. PubMed ID: 11190867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.